Trials / Completed
CompletedNCT04706884
NEW MONITORING IN DIFFERENTIAL DIAGNOSIS OF HYPERLACTATHEMIA IN CARDIOPULMONARY BYPASS SURGERY
EFFECT OF CEREBRAL OXYGEN SATURATION ON THE ETIOLOGY OF EARLY POSTOPERATIVE HYPERLACTATEMIA: NEW INDICATION FOR KNOWN MONITORING IN CARDIOPULMONARY BYPASS SURGERY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Acibadem University · Academic / Other
- Sex
- All
- Age
- 43 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Objective: The objective of the study was to investigate a reverse correlation between blood lactate levels and rSO2, and distinguish between hypoxic and non-hypoxic hyperlactatemia seen in the early postoperative period.
Detailed description
The objective of the prospective study was to investigate a reverse correlation between blood lactate levels and rSO2, and distinguish between hypoxic and non-hypoxic hyperlactatemia seen in the early postoperative period. Sixty American Society of Anesthesiologists (ASA) II-III patients were included in this study. Perioperative data, including age, weight, body surface area, gender, body temperature, preoperative co-morbidities, intraoperative and postoperative hemodynamic parameters, arterial blood gas analysis (ABG), cardiopulmonary bypass and aortic cross-clamp duration, flow rate, urine output, and blood product and inotropic agent usage, were recorded. Postoperative plasma lactate levels were measured simultaneously with cerebral tissue oxygen saturation (rSO2) in both cerebral hemispheres at 10 different time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Near infrared spectroscopy | The rSO2 (cerebral oxygen satutation) was continuously monitored by NIRS (Near infrared spectroscopy) with a sensor positioned on the forehead of the patient |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-02-01
- Completion
- 2019-03-01
- First posted
- 2021-01-13
- Last updated
- 2021-01-14
Locations
2 sites across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04706884. Inclusion in this directory is not an endorsement.